| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | Chief Operating Officer | Svp--product Development
2 companies
Krishnan Suma is a President, R&D at Krystal Biotech, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 121 sells.
Estimated insider holdings value: $489.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 25,000 | $263.21 | $6,580,270.41 | -0.2% | +12.5% | - | |
| Dec 4, 2025 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,000 | $220.15 | $11,007,332.86 | -0.2% | +19.4% | - | |
| Jul 16, 2025 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 35,873 | $150.39 | $5,395,000.82 | -0.3% | +25.3% | - | |
| Jul 10, 2025 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 14,127 | $150.27 | $2,122,834.96 | -0.2% | +25.0% | - | |
| Mar 13, 2025 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,000 | $177.79 | $8,889,524.59 | -0.3% | -21.3% | +39.4% | |
| Dec 13, 2024 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,000 | $164.80 | $8,240,023.05 | -0.2% | +8.4% | +49.5% | |
| Sep 12, 2024 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,000 | $197.77 | $9,888,276.35 | -0.2% | -4.4% | -26.6% | |
| Jun 11, 2024 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,000 | $175.76 | $8,788,061.50 | -0.2% | +5.8% | -21.3% | |
| Mar 11, 2024 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,701 | $171.24 | $8,682,176.41 | -0.2% | +3.8% | +8.5% | |
| Dec 11, 2023 | KRYS Krystal Biotech, Inc. | President, R&D | Sell | 50,000 | $105.67 | $5,283,290.75 | -0.4% | +60.7% | +75.2% |